SILO Silo Pharma rises 557 percent despite reporting a wider than expected Q4 2023 per share loss AHMA Ambitions leadership outlines core revenue growth drivers and looming industry headwinds following latest quarterly earnings release TDF Templeton leadership outlines targeted highgrowth Asia market investment priorities in latest quarterly earnings release